Croup as a manifestation of COVID-19 in infancy: a case series

Bhakti Sarangi; Guruprasad H. Shankar; Ajay Walimbe; K. C. Prithvichandra

doi:10.18203/2349-3291.ijcp20214164

Authors

Bhakti Sarangi Department of Pediatrics, Bharati Vidyapeeth Medical College, Pune, Maharashtra, India
Guruprasad H. Shankar Department of Pediatrics, Bharati Vidyapeeth Medical College, Pune, Maharashtra, India
Ajay Walimbe Department of Pediatrics, Bharati Vidyapeeth Medical College, Pune, Maharashtra, India
K. C. Prithvichandra Department of Pediatrics, Bharati Vidyapeeth Medical College, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20214164

Keywords:

SARS-CoV-2, Croup, Acute laryngotracheitis, Stridor, Budesonide

Abstract

The second wave of the COVID-19 pandemic in India brought with it an emerging clinical spectrum of the infection in children. Amongst these is the rarely reported presentation of croup, which otherwise remains a common clinical condition in infants caused by a variety of viruses and seen by pediatricians regularly. Airway manifestations of COVID-19 require reporting and unless their evaluation brings up any specific peculiarities, it is imperative to screen all such children presenting to the emergency department for SARS-CoV-2 infection. We hereby reported a series of three infants who were brought to us with typical features of croup including a mild fever, runny nose and indicators of subglottic inflammation including a hoarse voice, brassy cough and an inspiratory stridor. Each of them responded to conventional therapies for croup. However, the added conundrum of possible SARS-CoV-2 infection increases the relevance of rapid screening, assessment for complications and counselling in children presenting with croup.

Metrics

Metrics Loading ...

Author Biography

Bhakti Sarangi, Department of Pediatrics, Bharati Vidyapeeth Medical College, Pune, Maharashtra, India

Associate Professor and head of Pediatric critical care services, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune

References

Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS-CoV-2 infection in children: a systematic review and meta-analysis. Indian Pediatr. 2020;57(9):820-6.

Sarangi B, Shankar GH, Reddy VS. Virus-induced wheezing with COVID-19. Indian Pediatr. 2020;57(12):1183-5.

Venn AMR, Schmidt JM, Mullan PC. A case series of pediatric croup with COVID-19. Am J Emerg Med. 2020;735(20):30829.

Pitstick CE, Rodriguez KM, Smith AC, Herman HK, Hays JF, Nash CB. A curious case of croup: laryngotracheitis caused by COVID-19. Pediatrics. 2021;147(1):2020012179.

Rodrigues KK, Roosevelt GE. Acute inflammatory upper airway obstruction (croup, epiglottitis, laryngitis, and bacterial tracheitis). In: Kliengman RM, Geme JWS, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Text book of pediatrics. 21st ed. Philadelphia: Saunders Elsevier; 2019: 2202-6.

Hoek LV, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, et al. Croup is associated with the novel coronavirus NL63. PLoS Med. 2005;2(8):240.

Hanna J, Brauer PR, Morse E, Berson E, Mehra S. Epidemiological analysis of croup in the emergency department using two national datasets. Int J Pediatr Otorhinolaryngol. 2019;126:109641.

Ortiz-Alvarez O. Acute management of croup in the emergency department. Paediatr Child Health. 2017;22(3):166-9.

RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693-704.

Ramakrishnan S, Nicolau DV, Langford B, Mahdi M, Jeffers H, Mwasuku C, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021;9(7):763-72.

Aghdam MK, Mirzaee HS, Eftekhari K. Croup is one of the clinical manifestations of novel Coronavirus in children. Case Rep Pulmonol. 2021;2021:8877182.